Alain Lescoat
Vita-Salute San Raffaele University(IT)Inserm(FR)Inserm(FR)École des Hautes Études en Santé Publique(FR)University of Michigan(US)Université Rennes 2(FR)University Hospital of Zurich(CH)Institut de Recherche en Santé, Environnement et Travail(FR)Hôpital Nord(FR)Scleroderma Foundation(US)Université Bretagne Loire(FR)Centre Hospitalier Universitaire de Rennes(FR)Centre Hospitalier Universitaire de Rennes(FR)Université de Rennes(FR)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Inflammatory Myopathies and Dermatomyositis, Dermatologic Treatments and Research, Occupational and environmental lung diseases
Most-Cited Works
- → Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study(2019)185 cited
- → Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease(2020)179 cited
- → EULAR recommendations for the treatment of systemic sclerosis: 2023 update(2024)173 cited
- → Systemic Sclerosis–Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration–Approved Therapies in Clinical Practice(2021)121 cited
- → Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis(2020)82 cited
- → Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis(2022)74 cited